BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17660059)

  • 21. Intracerebral hemorrhage during fibrinolytic therapy in children: a review of the literature of the last thirty years.
    Zenz W; Arlt F; Sodia S; Berghold A
    Semin Thromb Hemost; 1997; 23(3):321-32. PubMed ID: 9255912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
    Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
    Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator.
    Kase CS; Pessin MS; Zivin JA; del Zoppo GJ; Furlan AJ; Buckley JW; Snipes RG; LittleJohn JK
    Am J Med; 1992 Apr; 92(4):384-90. PubMed ID: 1558085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intraventricular bleeding after the use of thrombolytics in a cocaine user.
    LoVecchio F; Nelson L
    Am J Emerg Med; 1996 Nov; 14(7):663-4. PubMed ID: 8906766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Complications of thrombolytic treatment of acute myocardial infarction].
    Ugeskr Laeger; 1990 Aug; 152(33):2370-2. PubMed ID: 2219479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT patterns of intracranial hemorrhage complicating thrombolytic therapy for acute myocardial infarction.
    Uglietta JP; O'Connor CM; Boyko OB; Aldrich H; Massey EW; Heinz ER
    Radiology; 1991 Nov; 181(2):555-9. PubMed ID: 1924804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The early risk of thrombolytic therapy for acute myocardial infarction: incidence, mechanisms and possible prevention.
    Verheugt FW
    J Cardiovasc Risk; 1998 Apr; 5(2):103-8. PubMed ID: 9821063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Local thrombolytic treatment of spontaneous intracerebral hemorrhage with plasminogen activator (rt-PA). Indications and limits].
    Schaller C; Rohde V; Hassler W
    Nervenarzt; 1995 Oct; 66(10):792. PubMed ID: 7501098
    [No Abstract]   [Full Text] [Related]  

  • 31. Intracerebral hematoma related to thrombolysis for myocardial infarction.
    Kaufman HH; McAllister P; Taylor H; Schmidt S
    Neurosurgery; 1993 Nov; 33(5):898-900; discussion 900-1. PubMed ID: 8264890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal intracerebral hemorrhage following thrombolytic therapy of embolic myocardial infarction in unsuspected infective endocarditis.
    Di Salvo TG; Tatter SB; O'Gara PT; Nielsen GP; DeSanctis RW
    Clin Cardiol; 1994 Jun; 17(6):340-4. PubMed ID: 8070153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lingual haematoma after thrombolysis for acute myocardial infarction].
    Jaffrelot M; Bourrigan P; Cracan A; Dewilde J; Mehu G
    Ann Fr Anesth Reanim; 2005 Mar; 24(3):306-7. PubMed ID: 15792570
    [No Abstract]   [Full Text] [Related]  

  • 35. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombolytic therapy in acute ischemic stroke.
    Clark WM; Lyden PD; Madden KP; Zivin JA
    N Engl J Med; 1997 Jan; 336(1):65-6; author reply 66-7. PubMed ID: 8984333
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiac tamponade mimicking ventricular rupture after thrombolysis for acute myocardial infarction.
    Imperadore F; Spagnolli W; Martinelli L; Musuraca G; De Girolamo P; Maines M; Vergara G
    Minerva Cardioangiol; 2003 Aug; 51(4):417-8. PubMed ID: 12900724
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
    Kandzari DE; Granger CB; Simoons ML; White HD; Simes J; Mahaffey KW; Gore J; Weaver WD; Longstreth WT; Stebbins A; Lee KL; Califf RM; Topol EJ;
    Am J Cardiol; 2004 Feb; 93(4):458-61. PubMed ID: 14969623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bilateral intracranial hemorrhage following thrombolytic therapy with alteplase (rTPA) in acute myocardial infarction].
    Arbol Linde F; Marcos Sánchez F; Merlo González V; Simón Martín A; Quintana Díaz M; López Onega P
    An Med Interna; 2002 Nov; 19(11):605-6. PubMed ID: 12522906
    [No Abstract]   [Full Text] [Related]  

  • 40. Mental Dullness after thrombolytic therapy.
    Woo KS; Chan HC; Poon WS
    Postgrad Med J; 1997 Jun; 73(860):347-9. PubMed ID: 9246336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.